My Take: 4 Strong Growth Stocks to Buy This Week
Are you looking for new growth stocks for your portfolio? The idea was compelling a week ago when the market was roaring higher. Now, with fresh headwinds blowing, not so much.
Just bear in mind there are some growth stories that are too good to ignore, just as there are some growth stocks that are too beaten down to pass up. Here's a rundown of four stocks that are not only "on sale" by virtue of their recent weakness, but are also shares of companies with very bright futures. One or more of them could be a great buy for any investor on the hunt for above-average returns.
Drugmaker Sarepta Therapeutics (NASDAQ: SRPT) isn't exactly a household name; its focus on developing treatments for rare diseases (by design) keeps it relatively small. With such focus on usually underserved drug markets, however, a research and development (R) win can prove to be a relative windfall.
Source Fool.com
Sarepta Therapeutics Stock
The community is currently still undecided about Sarepta Therapeutics with 1 Buy predictions and 0 Sell predictions.
With a target price of 130 € there is a slightly positive potential of 8.02% for Sarepta Therapeutics compared to the current price of 120.35 €.
